Top Navigation
Livepositively
Profile Menu
Read
Write
Join Now
Login
Explore
Read
Write
Business
Marketing
SEO
Technology
Science
Web design
Mobile
Education
Travel
Finance
Health
Dental
Diet
Cooking
Lifestyle
Fashion
Women
Wedding
Sports
Home
Real Estate
Insurance
Family
Baby
Environment
Animals
Services
General
Newsletter
Contact
Sitemap
RSS
Join Now
Login
Livepositively
Livepositively
Join Now
Login
Toya Tang
Follow
Toya Tang
Unlocking the Future of Cancer Care: Bone-Targeting Therapy Development for Prostate Cancer
Prostate cancer is one of the most commonly diagnosed cancers among men worldwide. While many cases are treatable in the early stages, advanced prostate
August 22, 2025
Toya Tang
Alfa Cytology Unveils In Vitroand In VivoModels of Cancer for Preclinical Research
Alfa Cytology has unveiled the in vitro and in vivo models of cancer for preclinical research solutions. Alfa Cytology, a cancer therapeutic development and preclinical research
August 22, 2025
Toya Tang
AlfaCytology Announces Holistic Approach to RDC Development Services Supported by In VivoStudies in Radiopharmaceuticals
Alfa Cytology has announced RDC development services supported by In Vivo studies in radiopharmaceuticals. Alfa Cytology, a leading-edge biotech company engaged in cancer research, has released
July 08, 2025
Toya Tang
CAR-T Cell Therapy: Revolutionizing Cancer Treatment and Beyond
In the realm of medical science, few innovations offer as much promise and excitement as CAR-T cell therapy. Comprised of cutting-edge biotechnology, CAR-T cell therapy
July 08, 2025
Toya Tang
Oncolytic Bacterial Therapy Development Services: Pioneering Synergistic Approaches to Cancer Treatment
The fight against cancer has led to innovative and diverse therapeutic strategies, one of which is oncolytic bacterial therapy. This burgeoning field utilizes genetically modified
June 11, 2025
Toya Tang
Innovative Preclinical Alfa Cytology alfaCAR-T Solutions: Revolutionizing the CAR-T Development Platform
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy
May 14, 2025
Toya Tang
Alfa Cytology Introduces Specialized Therapeutic Development Services Targeting FAP for Precision Oncology Treatments
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. Alfa Cytology has introduced its groundbreaking initiative which
May 14, 2025
Toya Tang
Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs
In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. Among the most promising strategies in this
April 16, 2025
Toya Tang
Alfa Cytology Introduces Full-Scale ADCs Development Services Focused on Cancer Therapy.
Alfa Cytology has officially released its antibody-drug conjugates(ADCs) development services which demonstrates the dedication to fighting cancer through advanced treatment methods. Alfa Cytology, which stands at
April 16, 2025
Toya Tang
Understanding Synthetic Lethality and Parthanatos: A New Frontier in Cancer Treatment
In the ever-evolving landscape of cancer research, two intriguing concepts have emerged that are reshaping how scientists approach treatment: synthetic lethality and parthanatos. Both concepts
March 08, 2025
1
2
3
Send message to Toya Tang
×
Please
login
in order to be able to contact
Toya Tang
